Dominari Holdings IncNASDAQ:DOMH
- LAST PRICE2.7600
- TODAY'S CHANGE (%)0.0500 (1.8450%)
- Bid / Lots2.2500/ 1
- Ask / Lots2.9000/ 3
- Open / Previous Close2.8700 / 2.7100
- Day Range
- 52 Week Range
- Volume37,842
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | DOMH |
|---|---|---|
| 09:32 ET | 276 | 2.87 |
| 09:52 ET | 9768 | 3.1 |
| 09:57 ET | 4809 | 3.1 |
| 10:14 ET | 100 | 3.0559 |
| 10:37 ET | 17831 | 2.72 |
| 11:02 ET | 100 | 2.87 |
| 11:51 ET | 100 | 2.76 |
| 12:38 ET | 194 | 2.76 |
| 12:56 ET | 560 | 2.76 |
| 02:02 ET | 250 | 2.7515 |
| 02:24 ET | 200 | 2.76 |
| 03:12 ET | 100 | 2.8 |
| 03:50 ET | 360 | 2.7932 |
| 03:57 ET | 422 | 2.76 |
Apr 17, 2024
Dominari Securities LLC Continues Expansion of Its Capital Market Group with Senior Hires, from 8:56AM ET on Wednesday Apr 17, 2024 by Dow Jones
8:56AM ET on Wednesday Apr 17, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Dominari Holdings Inc | 16.1M | -0.6x | --- |
Talis Biomedical Corp | 16.4M | -0.3x | --- |
Avalo Therapeutics Inc | 13.4M | 0.0x | --- |
Senti Biosciences Inc | 13.7M | -0.1x | --- |
Lumos Pharma Inc | 22.7M | -0.7x | --- |
OncoCyte Corp | 20.3M | -0.8x | --- |
Company Information
Dominari Holdings Inc. is a holding company. The Company, through its various subsidiaries, is engaged in wealth management, investment banking, sales and trading and asset management. It operates through its wholly owned subsidiaries, including Dominari Financial Inc. (Dominari Financial) and Dominari Securities LLC (Dominari Securities). Dominari Securities offers and plans to offer a range of broker-dealer and registered investment adviser services. Its services include wealth management, investment banking, sales and trading, asset management and insurance products. Dominari Securities provides a comprehensive array of financial services to high-net-worth individuals and families, corporate executives, and public and private businesses. Dominari Securities also provides full-service brokerage, wealth planning and margin lending services. Dominari Securities’ investment banking division provides strategic advisory services and capital markets products to middle market businesses.
Contact Information
- Headquarters
- 725 FIFTH AVENUE, 22ND FLOORNEW YORK, NY, United States 10022
- Phone
- 212-393-4540
- Fax
- 302-674-5266
Executives
- Chairman of the Board, Chief Executive Officer
- Anthony Hayes
- Chief Executive Officer of Dominari Financial Inc, Director
- Kyle Wool
- Chief Financial Officer
- George Way
- Chief Operating Officer
- Christopher Devall
- Director
- Kyle Haug
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $16.1M |
|---|---|
Revenue (TTM) | $2.0M |
Shares Outstanding | 5.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.88 |
EPS | $-4.44 |
Book Value | $8.92 |
P/E Ratio | -0.6x |
Price/Sales (TTM) | 7.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,068.96% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
